1100 CAMPUS ROAD, PRINCETON, NJ
Financial Results, Press Release
News, Material Contracts
Announces Leadership Transition
Reports First Quarter 2026 Financial Results
Integra LifeSciences Enters $150 Million A/R Securitization Facility
Integra LifeSciences Adopts Change in Control Severance Program
Reports Third Quarter 2025 Financial Results
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report